115 related articles for article (PubMed ID: 3755791)
1. Differences in cardiac but not in neuroendocrine responses in healthy volunteers after administration of two antimuscarinic agents, atropine and pirenzepine.
Syvälahti EK; Ylitalo A
Life Sci; 1986 Sep; 39(9):843-50. PubMed ID: 3755791
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of metoclopramide on sympathetic and muscarinic responses after pretreatment with atropine and pirenzepine.
Syvälahti EK; Ylitalo A; Scheinin M; Tarvonen S; Laurén L
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):16-21. PubMed ID: 3403088
[TBL] [Abstract][Full Text] [Related]
3. The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects.
Jungmann E; Althoff PH; Hermann GJ; Schöffling K
Arzneimittelforschung; 1984; 34(9):1022-4. PubMed ID: 6391497
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers.
Poller U; Nedelka G; Radke J; Pönicke K; Brodde OE
J Am Coll Cardiol; 1997 Jan; 29(1):187-93. PubMed ID: 8996313
[TBL] [Abstract][Full Text] [Related]
5. Effect of pirenzepine and atropine on peptone meal-stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal ulcer and vagotomized patients.
Lazzaroni M; Sangaletti O; Del Soldato P; Bianchi Porro G
Digestion; 1985; 32(4):267-72. PubMed ID: 3840755
[TBL] [Abstract][Full Text] [Related]
6. The effect of neostigmine on metoclopramide-induced aldosterone secretion after the administration of muscarinic antagonists in man.
Sommers DK; Meyer EC; van Wyk M
Eur J Clin Pharmacol; 1990; 38(4):401-3. PubMed ID: 2344865
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of gastric emptying and secretion by pirenzepine and atropine in rats.
Scarpignato C; Girone MG; Tirelli F; Bertaccini G
Eur J Pharmacol; 1984 Jun; 101(3-4):193-200. PubMed ID: 6547908
[TBL] [Abstract][Full Text] [Related]
8. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog.
Hirschowitz BI; Fong J; Molina E
J Pharmacol Exp Ther; 1983 May; 225(2):263-8. PubMed ID: 6132990
[TBL] [Abstract][Full Text] [Related]
9. [MI cholinergic receptors of gastric secretion: current status].
Vatier J
J Pharmacol; 1985; 16 Suppl 2():145-69. PubMed ID: 2867250
[TBL] [Abstract][Full Text] [Related]
10. Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man.
Delitala G; Frulio T; Pacifico A; Maioli M
J Clin Endocrinol Metab; 1982 Dec; 55(6):1231-3. PubMed ID: 6897069
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of pirenzepine on muscarinic stimulation of rat pancreas.
Dehaye JP; Winand J; Hermans L; Poloczek P; Christophe J
Eur J Pharmacol; 1983 Sep; 92(3-4):259-64. PubMed ID: 6605251
[TBL] [Abstract][Full Text] [Related]
12. Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist.
Massara F; Ghigo E; Goffi S; Molinatti GM; Müller EE; Camanni F
J Clin Endocrinol Metab; 1984 Nov; 59(5):1025-6. PubMed ID: 6434584
[TBL] [Abstract][Full Text] [Related]
13. Contribution of vagal blockade to the tachycardia induced by the antimuscarinic agents atropine and pirenzepine.
Chassaing C; Boucher M; Breysse C; Duchêne-Marullaz P
J Auton Pharmacol; 1992 Oct; 12(5):359-68. PubMed ID: 1429747
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F
Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic cholinergic, but not serotoninergic mediation of arginine vasopressin response to metoclopramide in man.
Coiro V; Capretti L; Speroni G; Volpi R; Fagnoni F; Bianconi L; Schianchi L; Caiazza A; Chiodera P
Clin Endocrinol (Oxf); 1989 Oct; 31(4):491-8. PubMed ID: 2627749
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1-, but not 5-HT2-serotonergic, M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide in man.
Coiro V; Volpi R; Capretti L; Speroni G; Bianconi L; Cavazzini U; Marcato A; Buonanno G; Caiazza A; Chiodera P
Horm Res; 1990; 33(6):233-8. PubMed ID: 1963170
[TBL] [Abstract][Full Text] [Related]
17. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the action of pirenzepine and L-hyoscyamine on gastric acid secretion and other muscarinic effects.
Jaup BH; Stockbrügger RW; Dotevall G
Scand J Gastroenterol Suppl; 1980; 66():89-94. PubMed ID: 6941380
[No Abstract] [Full Text] [Related]
19. Difference in effects of pirenzepine and atropine on carbachol-induced pepsinogen secretion from isolated gastric glands.
Sakamoto C; Matozaki T; Nagao M; Baba S
Biochem Biophys Res Commun; 1986 Apr; 136(1):193-9. PubMed ID: 3754746
[TBL] [Abstract][Full Text] [Related]
20. Identification of muscarinic receptor subtype mediating colonic response to eating.
Narducci F; Bassotti G; Daniotti S; Del Soldato P; Pelli MA; Morelli A
Dig Dis Sci; 1985 Feb; 30(2):124-8. PubMed ID: 3838152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
